Cargando…
Monitoring hepatitis C virus treatment rates in an Opioid Treatment Program: A longitudinal study
BACKGROUND: Direct-acting antivirals (DAAs) are recommended for the treatment of hepatitis C virus (HCV) infection in patients treated with methadone or buprenorphine. AIM: To assess HCV treatment rates in an Opioid Treatment Program (OTP). METHODS: This longitudinal study included 501 patients (81....
Autores principales: | Sanvisens, Arantza, Rivas, Inmaculada, Faure, Eva, Espinach, Néstor, Hernandez-Rubio, Anna, Majó, Xavier, Colom, Joan, Muga, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579757/ https://www.ncbi.nlm.nih.gov/pubmed/33132641 http://dx.doi.org/10.3748/wjg.v26.i38.5874 |
Ejemplares similares
-
Sex-specific disease outcomes of HIV-positive and HIV-negative drug users admitted to an opioid substitution therapy program in Spain: a cohort study
por: Muga, Roberto, et al.
Publicado: (2014) -
Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections
por: Fuster, Daniel, et al.
Publicado: (2016) -
Hepatitis C infection substantially reduces survival of alcohol-dependent patients
por: Muga, Roberto, et al.
Publicado: (2018) -
Markers of Inflammation and Mortality in a Cohort of Patients With Alcohol Dependence
por: Fuster, Daniel, et al.
Publicado: (2015) -
Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008)